the U.S. State Department revealed that it is implementing visa restrictions on 13 associates of the Indian company KS International Traders, citing their involvement in the distribution of counterfeit pills containing fentanyl. The firm, based in Mumbai, has been identified as generating revenue through trafficking this potent synthetic opioid, described by President Donald Trump as a "weapon of mass destruction."
The visa curbs target individuals closely associated with KS International Traders, which has reportedly sold hundreds of thousands of these dangerous pills to Americans. State Department spokesperson Thomas Pigott stated, “Illicit fentanyl is killing too many Americans. Those complicit in poisoning Americans will be denied entry to the United States.”
This recent move aligns with previous actions taken against KS International Traders, including an earlier sanction involving the company and two Indian nationals for supplying similar illicit products. The increasing pressure on the opioid crisis has brought attention to international networks involved in the manufacturing and distribution of counterfeit medications.
Despite efforts to curb the flow of this deadly substance, the U.S. continues to face alarming rates of overdose deaths linked to fentanyl use, underscoring the urgency behind these visa restrictions. The government's crackdown on such entities highlights its commitment to combating the fentanyl crisis and the broader impacts of illegal drug trafficking on American communities.
The company’s website appears to be inaccessible, and there has been no immediate response from India's foreign and health ministries regarding the U.S. actions. The enforcement of these visa restrictions renders the ongoing collaborative efforts between the U.S. and India vital for dismantling the networks that perpetuate this public health crisis.
Published by Banx Network. This article is part of the Banx decentralized media programme, powered by the BXE token on the XRP Ledger.
